Profound Medical Corp. Segments Disclosure
16 | Segment reporting |
The Company’s operations are categorized into one industry segment, which is medical technology focused on magnetic resonance guided ablation procedures for the treatments to ablate the prostate gland, uterine fibroids, osteoid osteoma and nerves for palliative pain relief for patients with metastatic bone disease. The CODM regularly reviews the operating results of the Company on a consolidated basis as part of making decisions for allocating resources and evaluating performance. Further, the CODM is regularly provided with the consolidated expenses as noted on the consolidated statements of operations and comprehensive loss.
The following tables represent total revenue by geographic area, based on the location of the location of the reporting entity for the years ended December 31, 2025 and 2024, respectively:
For the year ended December 31, 2025 | ||||||||
Canada | USA | Germany | Total | |||||
| $ | | $ | | $ | | $ | |
Revenue |
|
|
| |||||
Recurring - non-capital | 862 | 8,095 | 773 | 9,730 | ||||
Capital equipment |
| 2,218 |
| 4,150 | — |
| 6,368 | |
| 3,080 |
| 12,245 | 773 |
| 16,098 | ||
For the year ended December 31, 2024 | ||||||||
Canada | USA | Germany | Total | |||||
| $ | | $ | | $ | | $ | |
Revenue |
|
|
| |||||
Recurring - non-capital | 891 | 6,458 | 891 | 8,240 | ||||
Capital equipment |
| 1,548 |
| 892 | — |
| 2,440 | |
| 2,439 |
| 7,350 | 891 |
| 10,680 | ||
The following tables represent other geographic information for the years ended December 31, 2025 and 2024, respectively:
For the year ended December 31, 2025 | ||||||||||||
Canada | USA | Germany | China | Finland | Total | |||||||
| $ | | $ | | $ | | $ | | $ | | $ | |
Total assets |
| 63,046 |
| 9,791 |
| 1,243 |
| 137 |
| 3,258 |
| 77,475 |
Intangible assets |
| 138 |
| — |
| — |
| — |
| — |
| 138 |
Property and equipment |
| 41 |
| 481 |
| — |
| — |
| 176 |
| 698 |
Right-of-use assets |
| 184 |
| — |
| — |
| — |
| — |
| 184 |
Amortization of intangible assets |
| 187 |
| — |
| — |
| — |
| — |
| 187 |
Depreciation of property and equipment |
| 51 |
| 322 |
| — |
| — |
| — |
| 373 |
For the year ended December 31, 2024 | ||||||||||||
Canada | USA | Germany | China | Finland | Total | |||||||
| $ | | $ | | $ | | $ | | $ | | $ | |
Total assets |
| 58,743 |
| 6,351 |
| 1,661 |
| 92 |
| 3,387 |
| 70,234 |
Intangible assets |
| 261 |
| — |
| — |
| — |
| — |
| 261 |
Property and equipment |
| 93 |
| 332 |
| — |
| — |
| — |
| 425 |
Right-of-use assets |
| 396 |
| — |
| — |
| — |
| — |
| 396 |
Amortization of intangible assets |
| 229 |
| — |
| — |
| — |
| — |
| 229 |
Depreciation of property and equipment |
| 66 |
| 641 |
| — |
| — |
| — |
| 707 |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 5, 2026 | Showing above |
| 2024 | Mar 7, 2025 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.